OS Therapies Inc. has announced that it has entered into inducement offer letter agreements with fewer than 10 accredited investors holding existing warrants to purchase up to 5,382,148 shares of the company’s common stock. Under the agreement, these warrant holders have agreed to exercise or pre-fund their warrants for cash at a reduced exercise price of $1.40 per share (or $1.399 per share for pre-funded warrants). In return, OS Therapies will issue new common stock purchase warrants to acquire up to an additional 5,382,148 shares at an exercise price of $1.40 per share. The company has also extended the offering period for this transaction from February 10, 2026, to March 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-016408), on February 13, 2026, and is solely responsible for the information contained therein.